Provided by Tiger Fintech (Singapore) Pte. Ltd.

Charles River Laboratories

156.70
+1.761.14%
Post-market: 156.700.00000.00%19:04 EDT
Volume:905.61K
Turnover:141.31M
Market Cap:7.70B
PE:-253.50
High:156.95
Open:154.93
Low:153.82
Close:154.94
Loading ...

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
7 hours ago

FDA Lifts Veil on Drug Approval Process: Four Chinese Pharma Rejections Expose Overseas Expansion Challenges

Market Watcher
·
16 Jul

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
16 Jul

Charles River Laboratories International Inc. Announces Second-Quarter 2025 Financial Results Release

Reuters
·
15 Jul

CFRA downgrades Charles River Labs (CRL) to a Hold

TIPRANKS
·
15 Jul

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
12 Jul

Morning Movers: Capricor Therapeutics plunges following CRL from FDA

TIPRANKS
·
11 Jul

Video: Capricor plunges after CRL, Performance Foods up after seeing interest

TIPRANKS
·
11 Jul

Capricor Receives FDA CRL for Deramiocel BLA

TIPRANKS
·
11 Jul

Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray

GlobeNewswire
·
11 Jul

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
11 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Warner Music Group, GeneDx

Reuters
·
10 Jul

Charles River Laboratories Shares up 2.3%; Citigroup Raises to Buy From Neutral

THOMSON REUTERS
·
09 Jul

BUZZ-U.S. STOCKS ON THE MOVE-FVCBankcorp, Venture Global, Boeing

Reuters
·
09 Jul

Charles River Labs Raised to Buy From Neutral by Citigroup

Dow Jones
·
09 Jul

BUZZ-Citi flags uncertainty on life science sector as funding shifts and tariffs bite

Reuters
·
09 Jul

S&P 500 Futures Up In Premarket Trading; AES, Bloom Energy Lead

Dow Jones
·
09 Jul

Charles River Laboratories International Inc : Citigroup Raises to Buy From Neutral; Raises Target Price to $200 From $150

THOMSON REUTERS
·
09 Jul

Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS) and Charles River Labs (CRL)

TIPRANKS
·
09 Jul

Citigroup Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts PT to $200 From $150

MT Newswires Live
·
09 Jul